GMOペパボ(3633) – [Summary]Consolidated Financial Results for the Three Months Ended March 31, 2022[Japanese GAAP]

URLをコピーする
URLをコピーしました!

開示日時:2022/05/09 15:31:00

損益

決算期 売上高 営業益 経常益 EPS
2018.12 820,100 46,773 47,541 88.55
2019.12 894,303 78,387 78,117 103.24
2020.12 1,101,404 92,725 93,867 157.86

※金額の単位は[万円]

株価

前日終値 50日平均 200日平均 実績PER 予想PER
2,523.0 2,581.22 4,017.985 18.01

※金額の単位は[円]

キャッシュフロー

決算期 フリーCF 営業CF
2018.12 40,408 67,466
2019.12 33,110 69,830
2020.12 89,251 125,336

※金額の単位は[万円]

▼テキスト箇所の抽出

Consolidated Financial Results for the Three Months Ended March 31, 2022 [Japanese GAAP] May 9, 2022 Company name: GMO Pepabo, Inc. Stock exchange listing: Tokyo Stock Exchange Code number: 3633 URL: https://pepabo.com/ Representative: Kentaro Sato, CEO and President Contact: Yoshito Igashima, CFO and Board Director Phone: +81-3-5456-3021 Scheduled date of filing quarterly securities report: May 13, 2022 Scheduled date of commencing dividend payments: ― Availability of supplementary briefing material on quarterly financial results: Available Schedule of quarterly financial results briefing session: Scheduled (for institutional investors and analysts) 1. Consolidated Financial Results for the Three Months Ended March 31, 2022 (from January 1, 2022 to (Amounts of less than one million yen are rounded down.) March 31, 2022) (1) Consolidated Operating Results Net sales (% indicates changes from the previous corresponding period.) Profit attributable to owners of parent Ordinary profit Operating profit Three months ended Million yen 2,535 March 31, 2022 March 31, 2021 2,911 (Note) Comprehensive income: Three months ended March 31, 2022: ¥191 million [(19.4)%] % Million yen 237 233 % Million yen 225 234 (12.9) 21.4 (3.8) 20.8 2.0 (3.0) % Million yen 170 185 % (8.1) 43.8 Three months ended March 31, 2021: ¥237 million [99.8%] Basic earnings per share Diluted earnings per share Three months ended Yen – March 31, 2022 March 31, 2021 34.82 (Note) Diluted earnings per share for the three months ended March 31, 2022 are not stated because there were Yen 32.05 35.09 no dilutive shares. (2) Consolidated Financial Position Total assets As of March 31, 2022 As of December 31, 2021 (Reference) Equity: As of March 31, 2022: ¥2,601 million Million yen 10,318 8,870 Million yen 2,617 2,953 As of December 31, 2021: ¥2,915 million Net assets Equity ratio % 25.2 32.9 1 2. Dividends 1st quarter-end Yen 2nd quarter-end Yen Annual dividends 3rd quarter-end Yen Fiscal year ended December 31, 2021 Fiscal year ending December 31, 2022 Fiscal year ending December 31, 2022 (Forecast) 0.00 0.00 0.00 0.00 Year-end Total Yen 68.00 Yen 68.00 0.00 0.00 74.00 74.00 (Note) Revision to the dividends forecast most recently announced: No 3. Consolidated Financial Results Forecast for the Fiscal Year Ending December 31, 2022 (from January 1, 2022 to December 31, 2022) (% indicates changes from the previous corresponding period.) Net sales Operating profit Ordinary profit Million yen % Million yen % Million yen Profit attributable to owners of parent % % Million yen Basic earnings per share Yen – – – – – – – – – 19.5 (Note) Revision to the financial results forecast most recently announced: No (Note) Figures of the forecast for the first half (cumulative) of the fiscal year ending December 31, 2022 are not 1,143 28.7 11,482 1,156 (3.3) 785 9.7 147.92 First half (cumulative) Full year prepared. (Note) The Company has adopted the Accounting Standard for Revenue Recognition, etc. (hereinafter “Revenue Recognition Standard”) from the beginning of the first quarter of the fiscal year ending December 31, 2022. Accordingly, the forecasts are based on the application of the said standard, etc. In accordance with the previous standard, for the fiscal year ending December 31, 2022, the Company forecasts net sales of ¥13,674 million (up 15.1% year-on-year), operating profit of ¥1,135 million (up 27.7% year-on-year), ordinary profit of ¥1,148 million (up 18.6% year-on-year), and profit attributable to owners of parent of ¥779 million (up 8.9% year-on-year). 2 * Notes: (1) Changes in significant subsidiaries during the three months ended March 31, 2022: No (Changes in specified subsidiaries resulting in changes in scope of consolidation) New: None Excluded: None (2) Adoption of special accounting methods in preparation of quarterly consolidated financial statements: No (3) Changes in accounting policies, changes in accounting estimates and retrospective restatement (4) Total number of issued shares (common shares) 1) Changes in accounting policies due to the revision of accounting standards: Yes 2) Changes in accounting policies other than 1) above: No 3) Changes in accounting estimates: No 4) Retrospective restatement: No 1) Total number of issued shares at the end of the period (including treasury stock): March 31, 2022: 5,468,700 shares December 31, 2021: 5,468,700 shares 2) Total number of treasury stock at the end of the period: March 31, 2022: 156,457 shares December 31, 2021: 161,721 shares 3) Average number of shares during the period: Three months ended March 31, 2022: 5,313,866 shares Three months ended March 31, 2021: 5,281,221 shares * These quarterly financial results are outside the scope of quarterly review by certified public accountants or audit firms. * Explanation of the proper use of financial results forecast and other notes The statements concerning future performance presented in this document are based on currently available information and certain preconditions which the Company believes to be reasonable at this time and does not constitute a guarantee of the Company to achieve. Actual results may be substantially different from these forecasts presented herein due to various factors. 3

この記事が気に入ったら
いいね または フォローしてね!

シェアしたい方はこちらからどうぞ
URLをコピーする
URLをコピーしました!